These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6611130)

  • 1. [18F]spiroperidol: a radiopharmaceutical for the in vivo study of the dopamine receptor.
    Welch MJ; Raichle ME; Kilbourn MR; Mintun MA
    Ann Neurol; 1984; 15 Suppl():S77-8. PubMed ID: 6611130
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison in animal models of 18F-spiroperidol and 18F-haloperidol: potential agents for imaging the dopamine receptor.
    Welch MJ; Kilbourn MR; Mathias CJ; Mintun MA; Raichle ME
    Life Sci; 1983 Oct; 33(17):1687-93. PubMed ID: 6633162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative study of [3H]haloperidol and [3H]spiroperidol binding to receptors on rat cerebral membranes.
    Howlett DR; Nahorski SR
    FEBS Lett; 1978 Mar; 87(1):152-6. PubMed ID: 631328
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of three 18F-labeled butyrophenone neuroleptic drugs in the baboon using positron emission tomography.
    Arnett CD; Shiue CY; Wolf AP; Fowler JS; Logan J; Watanabe M
    J Neurochem; 1985 Mar; 44(3):835-44. PubMed ID: 2579198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific binding of [11C]spiroperidol in rat brain in vivo.
    Arnett CD; Fowler JS; Wolf AP; MacGregor RR
    J Neurochem; 1983 Feb; 40(2):455-9. PubMed ID: 6185638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 3-N-(2-[18F]-fluoroethyl)-spiperone: a novel ligand for cerebral dopamine receptor studies with pet.
    Coenen HH; Laufer P; Stöcklin G; Wienhard K; Pawlik G; Böcher-Schwarz HG; Heiss WD
    Life Sci; 1987 Jan; 40(1):81-8. PubMed ID: 2948091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 77Br-p-bromospiperone: a ligand for in vivo labelling of dopamine receptors.
    Owen F; Poulter M; Mashal RD; Crow TJ; Veall N; Zanelli GD
    Life Sci; 1983 Aug; 33(8):765-8. PubMed ID: 6888192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 76Br-bromospiroperidol: a new tool for quantitative in-vivo imaging of neuroleptic receptors.
    Mazière B; Loc'h C; Hantraye P; Guillon R; Duquesnoy N; Soussaline F; Naquet R; Comar D; Mazière M
    Life Sci; 1984 Sep; 35(13):1349-56. PubMed ID: 6332966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetic modeling of receptor-ligand binding applied to positron emission tomographic studies with neuroleptic tracers.
    Logan J; Wolf AP; Shiue CY; Fowler JS
    J Neurochem; 1987 Jan; 48(1):73-83. PubMed ID: 2432176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exogenous l-dopa alters spiroperidol binding, in vivo, in the mouse striatum.
    De Jesus OT; Van Moffaert GJ; Dinerstein RJ; Friedman AM
    Life Sci; 1986 Jul; 39(4):341-9. PubMed ID: 3736329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The affinity of aromatic fluoride derivatives of phenothiazine neuroleptics to spiroperidol binding sites of dopamine receptors by the radioligand technic in vitro].
    Oelssner W; Peinhardt G; Büge A
    Pharmazie; 1985 May; 40(5):341-2. PubMed ID: 2863832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo binding of spiroperidol and bromospiroperidol at low drug loadings.
    DeJesus OT; Revenaugh JR; Dinerstein RJ; Friedman AM
    Life Sci; 1984 Nov; 35(21):2165-8. PubMed ID: 6493007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced [3H]spiroperidol binding in striatum of spontaneously hypertensive rat (SHR).
    Chiu P; Rajakumar G; Chiu S; Kwan CY; Mishra RK
    Eur J Pharmacol; 1982 Aug; 82(3-4):243-4. PubMed ID: 7128691
    [No Abstract]   [Full Text] [Related]  

  • 14. Neuroleptic drug-induced dopamine receptor supersensitivity: antagonism by L-prolyl-L-leucyl-glycinamide.
    Chiu S; Paulose CS; Mishra RK
    Science; 1981 Dec; 214(4526):1261-2. PubMed ID: 6117947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [18F]-N-Methylspiroperidol: the radioligand of choice for PETT studies of the dopamine receptor in human brain.
    Arnett CD; Fowler JS; Wolf AP; Shiue CY; McPherson DW
    Life Sci; 1985 Apr; 36(14):1359-66. PubMed ID: 3872397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of alloxan-induced diabetes on dopaminergic receptors in rat striatum and anterior pituitary.
    Serri O; Renier G; Somma M
    Horm Res; 1985; 21(2):95-101. PubMed ID: 3979949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [3H]Haloperidol and [3H]spiroperidol binding in rat striatum during ageing.
    Govoni S; Spano PF; Trabucchi M
    J Pharm Pharmacol; 1978 Jul; 30(7):448-9. PubMed ID: 27613
    [No Abstract]   [Full Text] [Related]  

  • 18. 3-(2'-[18F]fluoroethyl)spiperone: in vivo biochemical and kinetic characterization in rodents, nonhuman primates, and humans.
    Barrio JR; Satyamurthy N; Huang SC; Keen RE; Nissenson CH; Hoffman JM; Ackermann RF; Bahn MM; Mazziotta JC; Phelps ME
    J Cereb Blood Flow Metab; 1989 Dec; 9(6):830-9. PubMed ID: 2531146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3H-Spiroperidol binding to dopamine receptors in rat striatal membranes: influence of loxapine and its hydroxylated metabolites.
    Coupet J; Rauh CE
    Eur J Pharmacol; 1979 Apr; 55(2):215-8. PubMed ID: 456420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of lipophilicity on the in vivo localization of radiolabelled spiperone analogues.
    Moerlein SM; Laufer P; Stöcklin G
    Int J Nucl Med Biol; 1985; 12(5):353-6. PubMed ID: 3833821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.